SRU Biosystems, Molecular Probes | GenomeWeb

SRU Biosystems has announced the launch of its BIND system for drug discovery applications.

According to SRU, BIND enables label-free detection of biomolecular interactions. The system comprises the company's BIND Reader and 96- or 384-well microplate biosensors. The platform is based on a patented optical effect using a proprietary, nanostructured optical grating to provide sensitive measurement of binding on the biosensor surface, SRU said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.